Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Biotechnology > Gene Therapeutics & RNAi > Gene Therapy--Industry Impact
Category
Biotechnology (1524)
Antibody & Immunity (193)
Biomarker (168)
Biomaterials (56)
Biotechnology Equipment (349)
Gene Therapeutics & RNAi (104)
Genome-based Drug Discovery (204)
Molecular Targeted Therapeutics (51)
Personalized Medicine (57)
Regenerative Medicine (122)
Market Research Report

Gene Therapy--Industry Impact

Published by Technical Insights, Inc.
Published December, 2006 Product code 48434
Content info 125 Pages
Price
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


Gene Therapy--Industry Impact published by Technical Insights, Inc. in December, 2006. This report consists of 125 Pages and the price starts from US $ 6000.

Introduction

Abstract

This research service discusses global advances in the field of gene therapy.

Table of Contents

1 EXECUTIVE SUMMARY

  • Scope and Methodology
    • Scope
    • Methodology
  • Introduction and History of Gene Therapy
    • Introduction
    • History of Gene Therapy

2 TECHNOLOGY AND APPLICATIONS VIEWPOINT

  • Technology Primer
    • Gene delivery--Vectors; Vehicles; Chemical and Physical Methods
    • DNA Vaccines
    • Additional Approaches
  • Applications Analysis and Trends
    • Targets Closest to Market
    • Ocular Disorders--Macular Degeneration And Retinopathy
    • Diabetes
    • Cystic Fibrosis
    • Rheumatoid Arthritis
    • Types of Disorders
    • Coronary Artery Disease
    • Peripheral Artery Disease
    • Cancer
    • DNA Vaccines
  • Assessment of Stakeholder Innovation and Technology Transfer Opportunities--Influential Market Factors
    • Mergers and Acquisitions Analysis
    • Regulatory and Political Factors; Industry Trends

3 TECHNOLOGY ADOPTION FACTOR ANALYSIS

  • Regulatory Hurdles
    • Safety Issues and Regulatory Barriers
    • Clinical Trials
  • Technology or Product Development Restraints and Competing Technologies
    • Technical Barriers
    • Lack of Investor Confidence
    • Gene Patents; Cost and Other Barriers
    • Stem Cells and Other Cellular Therapies
  • Analysis of Drivers
    • Analysis of Funding Sources
    • Features and Benefits of Gene Therapy
    • Adoption Drivers for Gene Therapy

4 ASSESSMENT OF INNOVATIONS AND OPPORTUNITIES

  • Innovative Developments in North America--Gene Therapy
    • Targeting Cancer Cells with Antibody/Gene/Liposome Nanocomplex
    • Polymer Delivers IL-12 Gene Therapy for Cancer
    • Gene Therapy Promotes Blood Vessel Growth in Peripheral Artery Disease
    • Lentiviral Vectors in Development
    • p53 Gene Therapy for Esophageal Cancer
    • Collagen Used as Target for Cancer Gene Therapy
    • Nanotechnology Gene Therapy for Prostate Cancer
    • Microbubbles Release Therapeutic Genes with Ultrasound
    • Autoantigen-Plasmid Drug Promising against MS
    • Zinc-Finger Protein Agent for Diabetic Neuropathy
    • Gene Therapy for Epilepsy and Parkinson' s Disease
    • Gene Therapy for Osteoarthritis
    • Naked DNA for Cancer Gene Therapy
    • Bare Metal Stents Deliver Gene Therapy to Treat Heart Disease
    • Gene Immunotherapy--T Cells Transformed into Tumor Fighting Cells
    • Emphysema Gene Therapy
    • Hedgehog Agonist Gene for Diabetic Wound Healing
    • Nanoparticles for DNA Delivery
    • FGF Gene Therapy for Myocardial Ischemia
    • Neurturin Gene Therapy for Parkinson' s Disease in Phase II Trials
    • Light-Activated Gene Therapy Targets Knee Injuries; Other Tissue Repair
    • New Lipid Molecule Holds Promise for Gene Therapy
    • Additional Companies
  • Innovative Developments in North America--DNA Vaccines
    • Flu DNA Vaccine Candidate Delivered via Needle-Free Injection
    • DOGS Cation Compound Enhances DNA Vaccines
    • Short ISS DNA Sequences Stimulate Immune Responses
    • Cell-Free Production of DNA for Flu Vaccine
    • DNA Bird Flu Vaccine Protects Lab Animals
    • DNA West Nile Vaccine Triggers Immune Response in Human Subjects
    • HIV Vaccines
    • Leukemia Vaccine Uses Tumor Cells Transfected with GM-CSF Gene
    • Adenoviral TB Vaccine
    • Clinical Trial for Ebola Vaccine
  • Innovative Developments in Europe--Gene Therapy
    • Gene Therapy for Critical Limb Ischemia
    • Interferon Vector for Cutaneous Lymphoma
    • Belgian and Dutch Companies Seek Spinal Gene Therapies
    • Gene Therapy Appears to Cure Myeloid Disease in Human Subjects
    • Additional Companies
  • Innovative Developments in Europe--DNA Vaccines
    • Adoptive Cell Therapy for Melanoma Vaccine
    • E6 and E7 Genes in HPV Vaccine Clinical Trials
    • Vaccine for Kidney Cancer
    • HIV Vaccines
  • Innovative Developments in the Asia Pacific Region
    • Gendicine p53 Gene Therapy Follow-up
    • Gene Therapy Successfully Treats Hemophilia
    • Hepatocyte Growth Factor for Liver and Circulatory Disorders
    • DNA Ointment for Atopic Dermatitis

5 PATENTS AND DATABASE OF KEY INDUSTRY PARTICIPANTS

  • Patents
    • Key Patents (2005)
    • Key Patents (2006)
  • Database of Key Industry Participants
    • Corporate Sector
    • Laboratories and Universities

6 DECISION SUPPORT DATABASE

  • Database Tables
    • Total Healthcare Expenditure--World (2002 to 2012)
    • Government Healthcare Expenditure--World (2002 to 2012)
    • Private Healthcare Expenditure--World (2002 to 2012)
Back to Top